Next Article in Journal
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
Next Article in Special Issue
First Insight into the Neuroprotective and Antibacterial Effects of Phlorotannins Isolated from the Cell Walls of Brown Algae Fucus vesiculosus and Pelvetia canaliculata
Previous Article in Journal
Red Palm Oil Ameliorates Oxidative Challenge and Inflammatory Responses Associated with Lipopolysaccharide-Induced Hepatic Injury by Modulating NF-κβ and Nrf2/GCL/HO-1 Signaling Pathways in Rats
Previous Article in Special Issue
Phlorotannins of the Brown Algae Sargassum vulgare from the Mediterranean Sea Coast
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Opinion

Selenoprotein: Potential Player in Redox Regulation in Chlamydomonas reinhardtii

by
Sandip A. Ghuge
1,
Ulhas Sopanrao Kadam
2,* and
Jong Chan Hong
2,3,*
1
Agricultural Research Organization (ARO), The Volcani Institute, P.O. Box 15159, Rishon LeZion 7505101, Israel
2
Division of Life Science and Division of Applied Life Science (BK21 Four), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju 52828, Gyeongnam, Korea
3
Division of Plant Sciences, University of Missouri, Columbia, MO 65211, USA
*
Authors to whom correspondence should be addressed.
Antioxidants 2022, 11(8), 1630; https://doi.org/10.3390/antiox11081630
Submission received: 6 July 2022 / Revised: 16 August 2022 / Accepted: 18 August 2022 / Published: 22 August 2022
(This article belongs to the Special Issue Antioxidants in Algae: Extraction, Components, and Applications)

Abstract

:
Selenium (Se) is an essential micro-element for many organisms, including Chlamydomonas reinhardtii, and is required in trace amounts. It is obtained from the 21st amino acid selenocysteine (Sec, U), genetically encoded by the UGA codon. Proteins containing Sec are known as selenoproteins. In eukaryotes, selenoproteins are present in animals and algae, whereas fungi and higher plants lack them. The human genome contains 25 selenoproteins, most of which are involved in antioxidant defense activity, redox regulation, and redox signaling. In algae, 42 selenoprotein families were identified using various bioinformatics approaches, out of which C. reinhardtii is known to have 10 selenoprotein genes. However, the role of selenoproteins in Chlamydomonas is yet to be reported. Chlamydomonas selenoproteins contain conserved domains such as CVNVGC and GCUG, in the case of thioredoxin reductase, and CXXU in other selenoproteins. Interestingly, Sec amino acid residue is present in a catalytically active domain in Chlamydomonas selenoproteins, similar to human selenoproteins. Based on catalytical active sites and conserved domains present in Chlamydomonas selenoproteins, we suggest that Chlamydomonas selenoproteins could have a role in redox regulation and defense by acting as antioxidants in various physiological conditions.

1. Introduction

Many organisms, including bacteria and humans, require Selenium (Se) as an essential trace element. Se is known to have various roles essentially related to redox homeostasis. Moreover, Se in trace amounts provides various health benefits such as improving immunity and preventing heart diseases and cancer [1,2,3,4,5]. Selenocysteine (Sec, U), the 21st amino acid, is Se’s main biologically active and available form. Sec is encoded by the UGA stop codon followed by co-translational insertion into selenoproteins in response to various elements involved in the Sec biosynthesis pathway. Selenoproteins are present in animals, bacteria, and archaea, whereas fungi, higher plants, and yeast lack selenoproteins. However, plants have cysteine-containing homologs of selenoprotein (hereafter referred to as Cys-homologs) [6].
Sec biosynthesis is highly complex, follows a unique translation process compared to other amino acid syntheses, and requires various cis- and trans-acting elements [7,8,9,10,11]. The Sec biosynthesis pathway is different in prokaryotes and eukaryotes. Here, we focus on Chlamydomonas selenoproteins; hence, we have covered the Sec biosynthesis pathway of eukaryotes only in the next part. In all organisms containing selenoproteins, the Sec biosynthesis starts with serylation of a specialized tRNASec, catalyzed by a seryl-tRNA synthetase (SerRS). Next, O-phosphoseryl-tRNASec kinase (PSTK), phosphorylates the seryl moiety of Sec (Ser-tRNASec) followed by replacement of the phosphoryl group with a selenol moiety by O-phosphoseryl-tRNA:selenocsteinyl-tRNA synthase (SepSecS) [12,13,14,15,16]. Here, selenol moiety is provided by the enzyme Sec lyase, which extracts Se from existing Sec, and is further used by selenophosphate synthetase (SPS2) to form selenophosphate [14,17]. Once Sec-tRNASec is synthesized, translation of UGA requires Sec-specific elongation factor (eEFSec) and SECIS binding protein 2 (SBP2) to recruit Sec-tRNASec to the ribosome in addition to the SECIS element [18,19,20]. SECIS is in the cis-element, forming a hairpin structure, and is present in selenoprotein in 3′-UTR [21,22,23,24]. In addition, after tRNA release, the ribosomal protein eL30 binds to SECIS and displaces SBP2 in eukaryotes and archaea [25].

2. Selenoproteins and Cysteine-Containing Homologs

Cysteine (Cys) is a principal sulfur-containing amino acid, while Sec is a Se-containing amino acid. Sec is structurally similar to Cys, except for the selenol group instead of the thiol group (Figure 1). Se and sulfur are chalcogens; thus, Sec and Cys share specific chemical properties. Nevertheless, there are slight differences in terms of electronegativity, oxidation state, and atomic radius between Se and sulfur. Se has a longer atomic radius and longer bond lengths than sulfur. Se clearly has unique chemical properties that differ from sulfur, but perhaps the similarities between the two elements are more striking. Slight differences in the electronic structures of sulfur and Se are enough to give selenoproteins distinctive catalytic potential [26,27]. Moreover, Sec has a lower pKa (~5.2) than Cys (~8.0); this way, it can exist as a nucleophile without electrostatic interactions, and hence, Sec is more reactive than Cys under physiological conditions [28]. Selenoproteins are more highly resistant to irreversible oxidation under severe oxidative stress conditions than their Cys-homologues [6,29]. Previous reports of Sec residue elimination, Sec residue alkylation at pH 6.5, and Sec substitution with Cys result in reduced catalytic efficiency of selenoprotein [30,31,32,33,34].
Human selenoproteins broadly can be classified into two groups based on the position of Sec amino acid in selenoprotein. In a group, I Sec is positioned at the C-terminal region, while in a group, II Sec is positioned at the N-terminal region. Group I includes thioredoxin reductases (TrxR), Selenoprotein I (SelI), SelK, SelO, SelR, and SelS, while Group II includes glutathione peroxidases (GPX), SelM, SelN, SelT, SelV, and SelW [36]. The human genome codes for 25 selenoproteins, most of which are involved in oxidative stress responses and redox signaling [2,37]. A common feature observed in Cys-homologues where Cys is present instead of Sec includes a conserved CXXC motif. CXXC motif alterations have been observed to affect the protein’s redox potential, its ability to function as a disulfide isomerase, and its interaction with folding protein substrates and oxidants [34]. Amongst human selenoproteins, SelV, SelW, Sep15, SelM, SelT, SelP, and others contain a CXXU motif instead of a CXXC motif at the Trx active site, indicating its antioxidant potential. Human selenoproteins contain Sec in the catalytic site identified for carrying out various redox functions, including redox signaling, antioxidant defense, and the regulation of redox homeostasis. However, there are also various selenoproteins from a human whose role is yet to know, including SelH, SelI, SelM, SelO, SelV, and SelW [36,37,38,39]. Isolation and quantification of selenoproteins are essential aspects due to its antioxidant properties. Isolation of selenoproteins, particularly selenoprotein P, is carried out using immunoaffinity precipitation, chromatography (using antibodies), chemical affinity, and immobilized metal affinity methods, which are further characterized using MS-based methods [40]. Recombinant selenoprotein production in E. coli is another widely used area for selenoprotein production. Mammalian TrxR selenoprotein obtains higher expression when expressed recombinantly in E. Coli with certain modifications [41,42]. For recombinant TrxR purification, a redox-active Sel-tag was developed. This tag can be used for one-step purification of tagged protein, selenolate-targeted fluorescent labeling, as well as selenolate-targeted radiolabeling can be purified using protocol [43,44].

3. Selenoproteins from Algae

Till 2002, selenoproteins were known only in animals. Interestingly ten selenoproteins were identified in C. reinhardtii, including methionine-S-sulfoxide reductase (MsrA), a selenoprotein specific to Chlamydomonas and not found in other organisms. Out of 10 Chlamydomonas selenoproteins, two selenoproteins, namely, GPX and SelW1, were identified at the protein level using mass spectrometry, while the rest of the amino acids were identified using genomic and EST databases. Moreover, the same study also reports that a selenocysteyl-tRNA (Sec tRNA) explicitly recognizes the UGA codon [45,46]. Further, more than 1000 selenoprotein genes from 42 selenoprotein families were predicted from genomic (36 organisms) and/or transcriptomic (including EST) datasets of 137 species of algae by using various bioinformatics approaches. Of them, 19 selenoproteins including AhpC, DsbA, SPS, GPX, DIO, TrxR, Sel F, Sel K, Sel M, MsrB, Sel S, Sel T, and SelW were also reported in animals [47,48]. GPX, TrxR, Sel U, and Sel T were the most abundant selenoproteins in algae, as these were found in more than half of the 36 genomes [47], while in specifically Chlamydomonas genome, GPX and SelW1 were the most abundant selenoproteins [45]. Further, we will discuss the known role of selenoproteins in humans, followed by the information available on selenoproteins from Chlamydomonas. We focused on Chlamydomonas selenoproteins only as these are identified by various groups [45,46,47].

3.1. Glutathione Peroxidase (GPX)

Selenoprotein glutathione peroxidase (GPX) is a cellular antioxidant enzyme that catalyzes the reduction of hydrogen peroxide, lipid hydroperoxides, and other organic hydroperoxides by oxidizing glutathione and, thus, helps to protect cells against oxidative damage [49,50]. The GPX family is widespread in living organisms, from archaea to bacteria to eukarya domains. In the case of mammals, five out of eight are selenoprotein GPX [51]. Loss of GPX activity is associated with muscle disorders [52], cancer [53,54], hepatopathies [55], renal failure [56,57], and neurological disorders such as Parkinson’s disease and Alzheimer’s disease [58,59,60]. It has been observed that mammalian selenoprotein GPXs have much higher activity than plant GPXs containing Cys [61]. Interestingly, mammalian selenoprotein GPX activity declines drastically when Sec is replaced by Cys [62]. The peculiar role of various selenoprotein GPXs are listed below in Table 1. In the case of Chlamydomonas, two selenoprotein GPX (GPX1-accession no. AY051144; GPX2- Gene Identifier from Phytozome- Cre08.g358525) were identified both containing Sec residue. Out of the two GPX selenoenzyme, in one GPX, the presence of Sec residue is confirmed at the proteomics level using mass spectrometry [45,46]. Moreover, its subcellular location is suggested in the mitochondria [46]. Another GPX is identified using Chlamydomonas EST and genomic databases [45].

3.2. Thioredoxin Reductase (TrxR)

TrxRs are prominent selenoproteins enzymes that are known to regulate redox metabolism. Various studies suggest that human TrxR inhibits multiple stages of tumor progression [74,75,76]. Moreover, its loss or overexpression in humans is linked with the onset of several diseases, such as cancer, cardiovascular diseases, type II diabetes, neurological disorders, and human immunodeficiency virus infection [77,78,79,80]. Some of the important roles of TrxR are mentioned below in Table 1. Generally, TrxR contains an N-terminal redox center with a ‘CVNVGC’ conserved sequence and a C-terminal redox center with GCUG conserved amino acid sequence [81,82,83]. One TrxR selenoprotein (accession no. AF494052) was found in the Chlamydomonas genome [45,47]. Interestingly, TrxR from Chlamydomonas contains both conserved sequences at the N- and C-terminals with Sec amino acid residue C-terminal catalytic region (Figure 2).

3.3. Other Selenoproteins

In addition, to two GPXs and a TrxR, there are seven selenoproteins found in Chlamydomonas, namely, Selenoprotein (Sel) K (accession no. AAN32902), Sel M1 (accession no. AAN32905), Sel M2 (accession no. AAN32900), Sel T (Gene Identifier from Phytozome- Cre14.g616950, Sel W1 (accession no. AAN32901), Sel W2 (accession no. XP_001693902), and Chlamydomonas specific selenoprotein MsrA (accession no. AAN32904) [45]. Human SelT knockdown mutant induces expression of another selenoprotein gene Sel W along with oxidoreductase genes, indicating a role of SelT in redox regulation [84]. Moreover, in humans, SelT was found to prevent severe movement impairment in Parkinson’s disease by protecting dopaminergic neurons against oxidative stress [85]. However, most selenoproteins such as SelM and SelW have not been explored to find out its function. Interestingly Chlamydomonas, selenoproteins Sel M1, Sel M2, SelT, SelW1, and SelW2 contain a CXXU motif instead of the CXXC motif of the Trx active site (Figure 3), as they have been found in human selenoprotein, indicating its antioxidant potential [34].

4. Selenoproteins from Chlamydomonas Can Be Potential Antioxidants

It has been observed that Se is required for optimal growth of Chlamydomonas [45]. To the best of our knowledge, no reported study points out the role of selenoproteins in the Chlamydomonas and other algae until now. It has been observed that Sec biosynthesis machinery and selenoproteins containing Sec are present in Chlamydomonas but during evolution from the other amino acid biosynthesis pathways. Chlamydomonas and other green algae maintain all these enzymes in their genome, suggesting that selenoproteins might have some key roles. Selenoproteins found in Chlamydomonas share various similarities with selenoproteins from humans, including conserved regions, catalytic sites, and the presence of Sec instead of Cys in catalytic sites. In Chlamydomonas, most of the selenoproteins contain catalytically important CXXU region corresponding to the CXXC motif in the Trx active site. In contrast, TrxR contains both catalytically necessary conserved sequences at N-terminal and C-terminal redox center. It has been noted that alteration in the amino acid residues between two Cys affects redox potentials which shows the critical role of this catalytic site in redox regulation [86]. Chlamydomonas selenoproteins contain active catalytic sites required for redox functioning, indicating a potential role of selenoproteins as an antioxidant and in redox signaling in various physiological conditions, as was the case with human and other organism selenoproteins [36,37,38,39]. It has been observed that Emiliania huxleyi and Aureococcus anophagefferens algae have the most selenoprotein genes. Interestingly, both algae showed strong resilience against several environmental conditions such as wide temperature range, low light, and broad geographical distribution [87], which could be attributed to its extensive repertoire of selenoproteins. This study also indirectly supports the hypothesis that selenoproteins may be involved in various redox functions related to plant defense against stress growth conditions.

5. Conclusions and Future Perspectives

This opinion article is focused on various selenoproteins from C. reinhardtii. After the discovery of 10 selenoproteins in Chlamydomonas and knowing that Se is necessary for optimal growth of Chlamydomonas, no study has been reported suggesting the precise role of selenoprotein in Chlamydomonas. This area has a huge potential to find its roles in various physiological conditions. Such studies not only unravel the role of selenoproteins but will also provide information about the evolution process of selenoprotein, which would be very helpful in finding how and why selenoprotein is lost in higher plants. Moreover, if the Chlamydomonas selenoproteins are involved in oxidoreductase functions, it opens a wide area to make a climate-resilient plant system to combat various biotic and abiotic stress conditions using selenoproteins.

Author Contributions

Conceptualization: S.A.G., U.S.K. and J.C.H.; writing—original draft preparation: S.A.G. and U.S.K.; writing—review and editing: S.A.G., U.S.K. and J.C.H.; visualization: S.A.G.; funding acquisition: U.S.K. and J.C.H. All authors have read and agreed to the published version of the manuscript.

Funding

Not applicable.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

This article presents the data generated and analyzed in figures or tables. Additional information on methods or materials used in this study will be made available upon request to the corresponding author.

Acknowledgments

The authors wish to acknowledge the funding from the BioGreen21 Agri-Tech Innovation Program, Rural Development Administration, Republic of Korea (Project PJ01623501 to JCH); and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2020R1A6A1A03044344 & 2020R1F1A1074027 to JCH; and 2022R1I1A1A01064372 to USK).

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Zoidis, E.; Seremelis, I.; Kontopoulos, N.; Danezis, G.P. Selenium-Dependent Antioxidant Enzymes: Actions and Properties of Selenoproteins. Antioxidants 2018, 7, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Avery, J.C.; Hoffmann, P.R. Selenium, Selenoproteins, and Immunity. Nutrients 2018, 10, 1203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Guillin, O.M.; Vindry, C.; Ohlmann, T.; Chavatte, L. Selenium, Selenoproteins and Viral Infection. Nutrients 2019, 11, 2101. [Google Scholar] [CrossRef] [Green Version]
  4. Seale, L.A. Selenocysteine β-Lyase: Biochemistry, Regulation and Physiological Role of the Selenocysteine Decomposition Enzyme. Antioxidants 2019, 8, 357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Qazi, I.H.; Angel, C.; Yang, H.; Zoidis, E.; Pan, B.; Wu, Z.; Ming, Z.; Zeng, C.-J.; Meng, Q.; Han, H.; et al. Role of Selenium and Selenoproteins in Male Reproductive Function: A Review of Past and Present Evidences. Antioxidants 2019, 8, 268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Johansson, L.; Gafvelin, G.; Arnér, E.S.J. Selenocysteine in proteins—Properties and biotechnological use. Biochim. Biophys. Acta-Gen. Subj. 2005, 1726, 1–13. [Google Scholar] [CrossRef] [Green Version]
  7. Bulteau, A.L.; Chavatte, L. Update on Selenoprotein Biosynthesis. Antioxid. Redox Signal. 2015, 23, 775–794. [Google Scholar] [CrossRef]
  8. Turanov, A.A.; Xu, X.-M.; Carlson, B.A.; Yoo, M.-H.; Gladyshev, V.N.; Hatfield, D.L. Biosynthesis of Selenocysteine, the 21st Amino Acid in the Genetic Code, and a Novel Pathway for Cysteine Biosynthesis. Adv. Nutr. Int. Rev. J. 2011, 2, 122–128. [Google Scholar] [CrossRef] [Green Version]
  9. Shetty, S.; Copeland, P.R. Molecular Mechanism of Selenoprotein P Synthesis. Biochim. Biophys. Acta-Gen. Subj. 2018, 1862, 2506–2510. [Google Scholar] [CrossRef]
  10. Liu, J.; Cheng, R.; Rozovsky, S. Synthesis and semisynthesis of selenopeptides and selenoproteins. Curr. Opin. Chem. Biol. 2018, 46, 41–47. [Google Scholar] [CrossRef]
  11. Serrão, V.H.B.; Silva, I.R.; da Silva, M.T.A.; Scortecci, J.F.; de Freitas Fernandes, A.; Thiemann, O.H. The unique tRNASec and its role in selenocysteine biosynthesis. Amino Acids 2018, 50, 1145–1167. [Google Scholar] [CrossRef] [PubMed]
  12. Xu, X.-M.; Carlson, B.A.; Mix, H.; Zhang, Y.; Saira, K.; Glass, R.S.; Berry, M.J.; Gladyshev, V.N.; Hatfield, D.L. Biosynthesis of Selenocysteine on Its tRNA in Eukaryotes. PLoS Biol. 2006, 5, e4. [Google Scholar] [CrossRef]
  13. Sherrer, R.L.; O’Donoghue, P.; Söll, D. Characterization and evolutionary history of an archaeal kinase involved in selenocysteinyl-tRNA formation. Nucleic Acids Res. 2008, 36, 1247–1259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Xu, X.-M.; Carlson, B.A.; Irons, R.; Mix, H.; Zhong, N.; Gladyshev, V.N.; Hatfield, D.L. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem. J. 2007, 404, 115–120. [Google Scholar] [CrossRef] [Green Version]
  15. Yuan, J.; Palioura, S.; Salazar, J.C.; Su, D.; O’Donoghue, P.; Hohn, M.J.; Cardoso, A.M.; Whitman, W.B.; Söll, D. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc. Natl. Acad. Sci. USA 2006, 103, 18923–18927. [Google Scholar] [CrossRef] [Green Version]
  16. Dobosz-Bartoszek, M.; Simonović, M. Structure and Mechanism of Selenocysteine Synthases. In Selenium; Springer International Publishing: Cham, Switzerland, 2016; pp. 101–112. [Google Scholar]
  17. Veres, Z.; Kim, I.; Scholz, T.; Stadtman, T. Selenophosphate synthetase. Enzyme properties and catalytic reaction. J. Biol. Chem. 1994, 269, 10597–10603. [Google Scholar] [CrossRef]
  18. Labunskyy, V.M.; Hatfield, D.L.; Gladyshev, V.N. Selenoproteins: Molecular Pathways and Physiological Roles. Physiol. Rev. 2014, 94, 739–777. [Google Scholar] [CrossRef] [Green Version]
  19. Ambrogelly, A.; Palioura, S.; Söll, D. Natural expansion of the genetic code. Nat. Chem. Biol. 2006, 3, 29–35. [Google Scholar] [CrossRef]
  20. Fu, X.; Söll, D.; Sevostyanova, A. Challenges of site-specific selenocysteine incorporation into proteins by Escherichia coli. RNA Biol. 2018, 15, 461–470. [Google Scholar] [CrossRef] [Green Version]
  21. Berry, M.; Banu, L.; Harney, J.; Larsen, P. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 1993, 12, 3315–3322. [Google Scholar] [CrossRef]
  22. Ringquist, S.; Schneider, D.; Gibson, T.; Baron, C.; Böck, A.; Gold, L. Recognition of the mRNA selenocysteine insertion sequence by the specialized translational elongation factor SELB. Genes Dev. 1994, 8, 376–385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Liu, Z.; Reches, M.; Groisman, I.; Engelberg-Kulka, H. The nature of the minimal ‘selenocysteine insertion sequence’ (SECIS) in Escherichia coli. Nucleic Acids Res. 1998, 26, 896–902. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Krol, A. Evolutionarily different RNA motifs and RNA–protein complexes to achieve selenoprotein synthesis. Biochimie 2002, 84, 765–774. [Google Scholar] [CrossRef]
  25. Chavatte, L.; Brown, B.A.; Driscoll, D.M. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat. Struct. Mol. Biol. 2005, 12, 408–416. [Google Scholar] [CrossRef]
  26. Wessjohann, L.A.; Schneider, A.; Abbas, M.; Brandt, W. Selenium in chemistry and biochemistry in comparison to sulfur. Biol. Chem. 2007, 388, 997–1006. [Google Scholar] [CrossRef]
  27. Arnér, E.S.J. Selenoproteins—What unique properties can arise with selenocysteine in place of cysteine? Exp. Cell Res. 2010, 316, 1296–1303. [Google Scholar] [CrossRef]
  28. Lobanov, A.V.; Hatfield, D.L.; Gladyshev, V.N. Eukaryotic Selenoproteins and Selenoproteomes. Biochim. Biophys. Acta-Gen. Subj. 2009, 1790, 1424–1428. [Google Scholar] [CrossRef] [Green Version]
  29. Mousa, R.; Dardashti, R.N.; Metanis, N. Selenium and Selenocysteine in Protein Chemistry. Angew. Chem. Int. Ed. 2017, 56, 15818–15827. [Google Scholar] [CrossRef]
  30. Gromer, S.; Wissing, J.; Behne, D.; Ashman, K.; Schirmer, R.H.; Floh, L.; Becker, K. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem. J. 1998, 332, 591–592. [Google Scholar] [CrossRef] [Green Version]
  31. Gorlatov, S.N.; Stadtman, T.C. Human Selenium-Dependent Thioredoxin Reductase from HeLa Cells: Properties of Forms with Differing Heparin Affinities. Arch. Biochem. Biophys. 1999, 369, 133–142. [Google Scholar] [CrossRef]
  32. Chung, S.S.; Kim, M.; Youn, B.-S.; Lee, N.S.; Park, J.W.; Lee, I.K.; Lee, Y.S.; Kim, J.B.; Cho, Y.M.; Lee, H.K.; et al. Glutathione Peroxidase 3 Mediates the Antioxidant Effect of Peroxisome Proliferator-Activated Receptor γ in Human Skeletal Muscle Cells. Mol. Cell. Biol. 2009, 29, 20–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Lee, S.-R.; Bar-Noy, S.; Kwon, J.; Levine, R.L.; Stadtman, T.C.; Rhee, S.G. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. USA 2000, 97, 2521–2526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Quan, S.; Schneider, I.; Pan, J.; Von Hacht, A.; Bardwell, J.C.A. The CXXC Motif Is More than a Redox Rheostat. J. Biol. Chem. 2007, 282, 28823–28833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res. 2019, 47, D1102–D1109. [Google Scholar] [CrossRef] [Green Version]
  36. Papp, L.V.; Lu, J.; Holmgren, A.; Khanna, K.K. From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health. Antioxid. Redox Signal. 2007, 9, 775–806. [Google Scholar] [CrossRef]
  37. Reeves, M.A.; Hoffmann, P.R. The human selenoproteome: Recent insights into functions and regulation. Cell. Mol. Life Sci. 2009, 66, 2457–2478. [Google Scholar] [CrossRef] [Green Version]
  38. Lee, B.C.; Peterfi, Z.; Hoffmann, F.W.; Moore, R.E.; Kaya, A.; Avanesov, A.; Tarrago, L.; Zhou, Y.; Weerapana, E.; Fomenko, D.E.; et al. MsrB1 and MICALs Regulate Actin Assembly and Macrophage Function via Reversible Stereoselective Methionine Oxidation. Mol. Cell 2013, 51, 397–404. [Google Scholar] [CrossRef] [Green Version]
  39. Hawkes, W.C.; Alkan, Z. Regulation of Redox Signaling by Selenoproteins. Biol. Trace Elem. Res. 2010, 134, 235–251. [Google Scholar] [CrossRef] [Green Version]
  40. Lamarche, J.; Ronga, L.; Szpunar, J.; Lobinski, R. Characterization and Quantification of Selenoprotein P: Challenges to Mass Spectrometry. Int. J. Mol. Sci. 2021, 22, 6283. [Google Scholar] [CrossRef]
  41. Arnér, E.S.J.; Sarioglu, H.; Lottspeich, F.; Holmgren, A.; Böck, A. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. J. Mol. Biol. 1999, 292, 1003–1016. [Google Scholar] [CrossRef]
  42. Arnér, E.S.J. Recombinant Expression of Mammalian Selenocysteine-Containing Thioredoxin Reductase and Other Selenoproteins in Escherichia coli. Methods Enzymol. 2002, 347, 226–235. [Google Scholar] [PubMed]
  43. Johansson, L.; Chen, C.; Thorell, J.-O.; Fredriksson, A.; Stone-Elander, S.; Gafvelin, G.; Arnér, E.S.J. Exploiting the 21st amino acid—purifying and labeling proteins by selenolate targeting. Nat. Chem. Biol. 2004, 1, 61–66. [Google Scholar] [CrossRef] [PubMed]
  44. Cheng, Q.; Stone-Elander, S.; Arnér, E.S.J. Tagging recombinant proteins with a Sel-tag for purification, labeling with electrophilic compounds or radiolabeling with 11C. Nat. Protoc. 2006, 1, 604–613. [Google Scholar] [CrossRef] [PubMed]
  45. Novoselov, S.; Rao, M.; Onoshko, N.V.; Zhi, H.; Kryukov, G.; Xiang, Y.; Weeks, D.P.; Hatfield, D.L.; Gladyshev, V.N. Selenoproteins and selenocysteine insertion system in the model plant cell system, Chlamydomonas reinhardtii. EMBO J. 2002, 21, 3681–3693. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Fu, L.-H.; Wang, X.-F.; Eyal, Y.; She, Y.-M.; Donald, L.J.; Standing, K.G.; Ben-Hayyim, G. A Selenoprotein in the Plant Kingdom. J. Biol. Chem. 2002, 277, 25983–25991. [Google Scholar] [CrossRef] [Green Version]
  47. Jiang, L.; Lu, Y.; Zheng, L.; Li, G.; Chen, L.; Zhang, M.; Ni, J.; Liu, Q.; Zhang, Y. The algal selenoproteomes. BMC Genom. 2020, 21, 699. [Google Scholar] [CrossRef]
  48. Jiang, L.; Ni, J.; Liu, Q. Evolution of selenoproteins in the metazoan. BMC Genom. 2012, 13, 446. [Google Scholar] [CrossRef] [Green Version]
  49. Flohé, L. Glutathione Peroxidase Brought into Focus. In Free Radicals in Biology; Pryor, W.A., Ed.; Academic Press: New York, NY, USA, 2012; Volume V, pp. 223–277. [Google Scholar]
  50. Flohé, L.; Günzler, W.A. [12] Assays of glutathione peroxidase. Methods Enzymol. 1984, 105, 114–120. [Google Scholar] [CrossRef]
  51. Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigoó, R.; Gladyshev, V.N. Characterization of Mammalian Selenoproteomes. Science 2003, 300, 1439–1443. [Google Scholar] [CrossRef] [Green Version]
  52. El Haddad, M.; Jean, E.; Turki, A.; Hugon, G.; Vernus, B.; Bonnieu, A.; Passerieux, E.; Hamade, A.; Mercier, J.; Laoudj-Chenivesse, D.; et al. Glutathione peroxidase 3, a new retinoid target gene, is crucial for human skeletal muscle precursor cell survival. J. Cell Sci. 2012, 125, 6147–6156. [Google Scholar] [CrossRef] [Green Version]
  53. Hu, Y.J.; Diamond, A.M. Role of glutathione peroxidase 1 in breast cancer: Loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003, 63, 3347–3351. [Google Scholar] [PubMed]
  54. Hu, Y.; Benya, R.V.; Carroll, R.E.; Diamond, A.M. Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer. J. Nutr. 2005, 135, 3021S–3024S. [Google Scholar] [CrossRef] [PubMed]
  55. Carlson, B.A.; Tobe, R.; Yefremova, E.; Tsuji, P.A.; Hoffmann, V.J.; Schweizer, U.; Gladyshev, V.N.; Hatfield, D.L.; Conrad, M. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016, 9, 22–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Zachara, B.A.; Gromadzinska, J.; Zbrog, Z.; Swiech, R.; Wasowicz, W.; Twardowska, E.; Jablonska, E.; Sobala, W. Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase. Acta Biochim. Pol. 2009, 56, 183–187. [Google Scholar] [CrossRef]
  57. Taccone-Gallucci, M.; Noce, A.; Bertucci, P.; Fabbri, C.; Manca-Di-Villahermosa, S.; Della-Rovere, F.R.; De Francesco, M.; Lonzi, M.; Federici, G.; Scaccia, F.; et al. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients. J. Trace Elem. Med. Biol. 2010, 24, 27–30. [Google Scholar] [CrossRef] [Green Version]
  58. Cardoso, B.R.; Hare, D.J.; Bush, A.I.; Roberts, B.R. Glutathione Peroxidase 4: A New Player in Neurodegeneration? Mol. Psychiatry 2017, 22, 328–335. [Google Scholar] [CrossRef] [Green Version]
  59. Hambright, W.S.; Fonseca, R.S.; Chen, L.; Na, R.; Ran, Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 2017, 12, 8–17. [Google Scholar] [CrossRef]
  60. Chen, L.; Hambright, W.S.; Na, R.; Ran, Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J. Biol. Chem. 2015, 290, 28097–28106. [Google Scholar] [CrossRef] [Green Version]
  61. Beeor-Tzahar, T.; Ben-Hayyim, G.; Holland, D.; Faltin, Z.; Eshdat, Y. A stress-associated citrus protein is a distinct plant phospholipid hydroperoxide glutathione peroxidase. FEBS Lett. 1995, 366, 151–155. [Google Scholar] [CrossRef] [Green Version]
  62. Stadtman, T.C. Selenocysteine. Annu. Rev. Biochem. 1996, 65, 83–100. [Google Scholar] [CrossRef]
  63. Rotruck, J.T.; Pope, A.L.; Ganther, H.E.; Swanson, A.B.; Hafeman, D.G.; Hoekstra, W.G. Selenium: Biochemical Role as a Component of Glutathione Peroxidase. Science 1973, 179, 588–590. [Google Scholar] [CrossRef] [PubMed]
  64. Burk, R.F. Molecular biology of selenium with implications for its metabolism 1. FASEB J. 1991, 5, 2274–2279. [Google Scholar] [CrossRef]
  65. Florian, S.; Krehl, S.; Loewinger, M.; Kipp, A.; Banning, A.; Esworthy, S.; Chu, F.-F.; Brigelius-Flohé, R. Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic. Biol. Med. 2010, 49, 1694–1702. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Brigelius-Flohé, R.; Banning, A.; Schnurr, K. Selenium-Dependent Enzymes in Endothelial Cell Function. Antioxid. Redox Signal. 2003, 5, 205–215. [Google Scholar] [CrossRef] [PubMed]
  67. Iwata, K.; Nishinaka, T.; Matsuno, K.; Yabe-Nishimura, C. Increased Gene Expression of Glutathione Peroxidase-3 in Diabetic Mouse Heart. Biol. Pharm. Bull. 2006, 29, 1042–1045. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Lee, Y.S.; Kim, A.Y.; Choi, J.W.; Kim, M.; Yasue, S.; Son, H.J.; Masuzaki, H.; Park, K.S.; Kim, J.B. Dysregulation of Adipose Glutathione Peroxidase 3 in Obesity Contributes to Local and Systemic Oxidative Stress. Mol. Endocrinol. 2008, 22, 2176–2189. [Google Scholar] [CrossRef] [Green Version]
  69. Thomas, J.P.; Maiorino, M.; Ursini, F.; Girotti, A.W. Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J. Biol. Chem. 1990, 265, 454–461. [Google Scholar] [CrossRef]
  70. Ursini, F.; Maiorino, M.; Roveri, A. Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx): More Than an Antioxidant Enzyme? Biomed. Environ. Sci. 1997, 10, 327–332. [Google Scholar]
  71. Seiler, A.; Schneider, M.; Förster, H.; Roth, S.; Wirth, E.K.; Culmsee, C.; Plesnila, N.; Kremmer, E.; Rådmark, O.; Wurst, W.; et al. Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death. Cell Metab. 2008, 8, 237–248. [Google Scholar] [CrossRef] [Green Version]
  72. Yoo, M.-H.; Gu, X.; Xu, X.-M.; Kim, J.-Y.; Carlson, B.A.; Patterson, A.D.; Cai, H.; Gladyshev, V.N.; Hatfield, D.L. Delineating the Role of Glutathione Peroxidase 4 in Protecting Cells Against Lipid Hydroperoxide Damage and in Alzheimer’s Disease. Antioxid. Redox Signal. 2010, 12, 819–827. [Google Scholar] [CrossRef] [Green Version]
  73. Dammeyer, P.; Damdimopoulos, A.E.; Nordman, T.; Jiménez, A.; Miranda-Vizuete, A.; Arnér, E.S.J. Induction of Cell Membrane Protrusions by the N-terminal Glutaredoxin Domain of a Rare Splice Variant of Human Thioredoxin Reductase 1. J. Biol. Chem. 2008, 283, 2814–2821. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Khan, I.A.; Ludueña, R.F. Possible regulation of the in vitro assembly of bovine brain tubulin by the bovine thioredoxin system. Biochim. Biophys. Acta (BBA)/Protein Struct. Mol. 1991, 1076, 289–297. [Google Scholar] [CrossRef]
  75. Shinozaki, Y.; Koizumi, S.; Ohno, Y.; Nagao, T.; Inoue, K. Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia 2006, 54, 606–618. [Google Scholar] [CrossRef] [PubMed]
  76. Hellfritsch, J.; Kirsch, J.; Schneider, M.; Fluege, T.; Wortmann, M.; Frijhoff, J.; Dagnell, M.; Fey, T.; Esposito, I.; Koelle, P.; et al. Knockout of Mitochondrial Thioredoxin Reductase Stabilizes Prolyl Hydroxylase 2 and Inhibits Tumor Growth and Tumor-Derived Angiogenesis. Antioxid. Redox Signal. 2015, 22, 938–950. [Google Scholar] [CrossRef]
  77. Kondo, N.; Nakamura, H.; Masutani, H.; Yodoi, J. Redox Regulation of Human Thioredoxin Network. Antioxid. Redox Signal. 2006, 8, 1881–1890. [Google Scholar] [CrossRef]
  78. Arnér, E.S.J. Focus on mammalian thioredoxin reductases—Important selenoproteins with versatile functions. Biochim. Biophys. Acta-Gen. Subj. 2009, 1790, 495–526. [Google Scholar] [CrossRef]
  79. Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem. Biophys. Res. Commun. 2010, 396, 120–124. [Google Scholar] [CrossRef] [Green Version]
  80. Gladyshev, V.N.; Stadtman, T.C.; Hatfield, D.L.; Jeang, K.-T. Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc. Natl. Acad. Sci. USA 1999, 96, 835–839. [Google Scholar] [CrossRef] [Green Version]
  81. Zhong, L.; Arnér, E.S.J.; Ljung, J.; Åslund, F.; Holmgren, A. Rat and Calf Thioredoxin Reductase Are Homologous to Glutathione Reductase with a Carboxyl-terminal Elongation Containing a Conserved Catalytically Active Penultimate Selenocysteine Residue. J. Biol. Chem. 1998, 273, 8581–8591. [Google Scholar] [CrossRef] [Green Version]
  82. Williams, C.H.; David Arscott, L.; Müller, S.; Lennon, B.W.; Ludwig, M.L.; Wang, P.F.; Veine, D.M.; Becker, K.; Heiner Schirmer, R. Thioredoxin Reductase: Two Modes of Catalysis Have Evolved. Eur. J. Biochem. 2000, 267, 6110–6117. [Google Scholar] [CrossRef] [Green Version]
  83. Snider, G.W.; Dustin, C.M.; Ruggles, E.L.; Hondal, R.J. A Mechanistic Investigation of the C-Terminal Redox Motif of Thioredoxin Reductase from Plasmodium falciparum. Biochemistry 2014, 53, 601–609. [Google Scholar] [CrossRef] [PubMed]
  84. Sengupta, A.; Carlson, B.A.; Labunskyy, V.M.; Gladyshev, V.N.; Hatfield, D.L. Selenoprotein T deficiency alters cell adhesion and elevates selenoprotein W expression in murine fibroblast cells. Biochem. Cell Biol. 2009, 87, 953–961. [Google Scholar] [CrossRef]
  85. Boukhzar, L.; Hamieh, A.; Cartier, D.; Tanguy, Y.; Alsharif, I.; Castex, M.; Arabo, A.; El Hajji, S.; Bonnet, J.-J.; Errami, M.; et al. Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease. Antioxid. Redox Signal. 2016, 24, 557–574. [Google Scholar] [CrossRef] [PubMed]
  86. Chivers, P.T.; Laboissière, M.C.; Raines, R.T. The CXXC motif: Imperatives for the formation of native disulfide bonds in the cell. EMBO J. 1996, 15, 2659–2667. [Google Scholar] [CrossRef]
  87. Gobler, C.J.; Berry, D.L.; Dyhrman, S.T.; Wilhelm, S.W.; Salamov, A.; Lobanov, A.V.; Zhang, Y.; Collier, J.L.; Wurch, L.L.; Kustka, A.B.; et al. Niche of harmful alga Aureococcus anophagefferens revealed through ecogenomics. Proc. Natl. Acad. Sci. USA 2011, 108, 4352–4357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Chemical structure of cysteine (MW: 103.01 Da; PubChem CID: 5862) and selenocysteine (MW: 168.05 Da; PubChem CID: 6326983) [35].
Figure 1. Chemical structure of cysteine (MW: 103.01 Da; PubChem CID: 5862) and selenocysteine (MW: 168.05 Da; PubChem CID: 6326983) [35].
Antioxidants 11 01630 g001
Figure 2. TrxR selenoprotein sequence from Chlamydomonas with conserved catalytic domains. Catalytic domain (CVNVGC and GCUG), underlined in bold; Sec, underlined bold red U; *—stop codon.
Figure 2. TrxR selenoprotein sequence from Chlamydomonas with conserved catalytic domains. Catalytic domain (CVNVGC and GCUG), underlined in bold; Sec, underlined bold red U; *—stop codon.
Antioxidants 11 01630 g002
Figure 3. Selenoproteins sequence from Chlamydomonas with conserved catalytic domains. Catalytic domain (CXXU), underscore and bold; Sec (U), underscore and bold in red; *—stop codon.
Figure 3. Selenoproteins sequence from Chlamydomonas with conserved catalytic domains. Catalytic domain (CXXU), underscore and bold; Sec (U), underscore and bold in red; *—stop codon.
Antioxidants 11 01630 g003
Table 1. Functions of some of the selenoproteins.
Table 1. Functions of some of the selenoproteins.
Selenoprotein (Containing Sec Residue)FunctionsReferences
Glutathione peroxidase 1 (GPX 1)As an antioxidant, also functions as Se storage house[63,64]
GPX 2As an antioxidant, anti-apoptotic function in the colon regulates mucosal homeostasis[65]
GPX 3As an antioxidant, preventing plasma LDL oxidation, functions in the reduction of H2O2 [66,67,68]
GPX 4As an antioxidant protects brain membranes from peroxidative degradation, catalyzes the reduction of hydroperoxides, inhibits lipid peroxidation[69,70,71,72]
GPX 6Unknown-
Thioredoxin reductases 1 (TrxR1)As an antioxidant, reduction of thioredoxin, actin polymerization for cell membrane restructuring[37,73]
TrxR2Regulation of mitochondrial redox homeostasis, Maintains thioredoxin in a reduced state[37]
TrxR3Unknown-
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ghuge, S.A.; Kadam, U.S.; Hong, J.C. Selenoprotein: Potential Player in Redox Regulation in Chlamydomonas reinhardtii. Antioxidants 2022, 11, 1630. https://doi.org/10.3390/antiox11081630

AMA Style

Ghuge SA, Kadam US, Hong JC. Selenoprotein: Potential Player in Redox Regulation in Chlamydomonas reinhardtii. Antioxidants. 2022; 11(8):1630. https://doi.org/10.3390/antiox11081630

Chicago/Turabian Style

Ghuge, Sandip A., Ulhas Sopanrao Kadam, and Jong Chan Hong. 2022. "Selenoprotein: Potential Player in Redox Regulation in Chlamydomonas reinhardtii" Antioxidants 11, no. 8: 1630. https://doi.org/10.3390/antiox11081630

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop